Medicure Drug Patent Portfolio
Medicure owns 2 orange book drugs protected by 7 US patents Given below is the list of Medicure's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8829186 | Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof | 19 Jan, 2031 | Active |
| US6770660 | Method for inhibiting platelet aggregation | 01 May, 2023 | Expired |
| US6136794 | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist | 29 Jan, 2019 | Expired |
| US5978698 | Angioplasty procedure using nonionic contrast media | 08 Oct, 2017 | Expired |
| US5733919 | Compositions for inhibiting platelet aggregation | 23 Oct, 2016 | Expired |
| US5965581 | Compositions for inhibiting platelet aggregation | 23 Oct, 2016 | Expired |
| US5972967 | Compositions for inhibiting platelet aggregation | 23 Oct, 2016 | Expired |
Latest Legal Activities on Medicure's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Medicure.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Recordation of Patent Grant Mailed
Critical
| 03 Aug, 2004 | US6770660 |
|
Patent Issue Date Used in PTA Calculation
Critical
| 03 Aug, 2004 | US6770660 |
|
Issue Notification Mailed
Critical
| 15 Jul, 2004 | US6770660 |
| Receipt into Pubs | 08 Jul, 2004 | US6770660 |
|
Application Is Considered Ready for Issue
Critical
| 06 Jul, 2004 | US6770660 |
| Dispatch to FDC | 06 Jul, 2004 | US6770660 |
|
Issue Fee Payment Received
Critical
| 15 Jun, 2004 | US6770660 |
|
Issue Fee Payment Verified
Critical
| 15 Jun, 2004 | US6770660 |
| Applicant Has Filed a Verified Statement of Small Entity Status in Compliance with 37 CFR 1.27 | 15 Jun, 2004 | US6770660 |
|
Change in Power of Attorney (May Include Associate POA)
Critical
| 14 Jun, 2004 | US6770660 |
|
Correspondence Address Change
Critical
| 11 Jun, 2004 | US6770660 |
| Receipt into Pubs | 01 Jun, 2004 | US6770660 |
| Receipt into Pubs | 08 Apr, 2004 | US6770660 |
| Workflow - File Sent to Contractor | 07 Apr, 2004 | US6770660 |
|
Mail Notice of Allowance
Critical
| 16 Mar, 2004 | US6770660 |
Medicure's Family Patents
Medicure Drug List
Given below is the complete list of Medicure's drugs and the patents protecting them.
1. Aggrastat
Aggrastat is protected by 6 patents, out of which all have expired. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US6770660 | Method for inhibiting platelet aggregation |
01 May, 2023
(2 years ago)
| Expired |
| US6136794 | Platelet aggregation inhibition using low molecular weight heparin in combination with a GP IIb/IIIa antagonist |
29 Jan, 2019
(6 years ago)
| Expired |
| US5978698 | Angioplasty procedure using nonionic contrast media |
08 Oct, 2017
(7 years ago)
| Expired |
| US5733919 | Compositions for inhibiting platelet aggregation |
23 Oct, 2016
(8 years ago)
| Expired |
| US5965581 | Compositions for inhibiting platelet aggregation |
23 Oct, 2016
(8 years ago)
| Expired |
| US5972967 | Compositions for inhibiting platelet aggregation |
23 Oct, 2016
(8 years ago)
| Expired |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Aggrastat's drug page
2. Zypitamag
Zypitamag is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US8829186 | Method for preparation of pitavastatin and pharmaceutical acceptable salts thereof |
19 Jan, 2031
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Zypitamag's drug page